Compulsory Licensing And Compounded Orkambi: Solutions For Excessive Prices In The Netherlands?

Compulsory licensing, new R&D models, and pharmaceutical compounding are among measures that could help secure lower drugs prices, according to a report from the Dutch Council for Public Health and Society.

SC1711_Purse-Pills_673872868_1200 — Are Compulsory Liceinsing and Compounding The Solutions To Excessive Pricing

Compulsory licensing, pharmacy compounding and new R&D models could be effective means of “enforcing socially acceptable” drug prices and encouraging the pharmaceutical industry to develop medicines more quickly, effectively and cheaply, according to a report from the Dutch Council for Public Health and Society (RVS).

The RVS has set out its recommendations to the Dutch minister for medical care, Bruno Bruins, in a report entitled...